nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.15	0.19	CbGpPWpGaD
Raltegravir—UGT1A1—urine—adrenal gland cancer	0.105	0.504	CbGeAlD
Raltegravir—CCR1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0803	0.101	CbGpPWpGaD
Raltegravir—UGT1A1—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0566	0.0716	CbGpPWpGaD
Raltegravir—CCR1—pituitary gland—adrenal gland cancer	0.0547	0.262	CbGeAlD
Raltegravir—CCR1—adrenal gland—adrenal gland cancer	0.0489	0.234	CbGeAlD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0474	0.06	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0361	0.0457	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0284	0.0359	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0253	0.032	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0216	0.0274	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0204	0.0258	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0193	0.0244	CbGpPWpGaD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0187	0.0236	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0185	0.0234	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0185	0.0234	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0148	0.0187	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0125	0.0158	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0122	0.0155	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.0112	0.0142	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0111	0.014	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.011	0.0138	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0109	0.0138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0102	0.0129	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00992	0.0125	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0099	0.0125	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00957	0.0121	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00756	0.00955	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00711	0.00898	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00664	0.00839	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00656	0.00829	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00634	0.00801	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00603	0.00762	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.006	0.00758	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00585	0.00739	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00576	0.00728	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MEN1—adrenal gland cancer	0.0055	0.00695	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00542	0.00685	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00427	0.0054	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.0042	0.0053	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00388	0.0049	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00356	0.0045	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00343	0.00434	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNAS—adrenal gland cancer	0.0034	0.0043	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—POMC—adrenal gland cancer	0.00334	0.00422	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00332	0.00419	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SDHB—adrenal gland cancer	0.00299	0.00377	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TERT—adrenal gland cancer	0.00286	0.00361	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BAD—adrenal gland cancer	0.00248	0.00314	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—POMC—adrenal gland cancer	0.00229	0.00289	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BRAF—adrenal gland cancer	0.00226	0.00286	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00219	0.00277	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—RRM1—adrenal gland cancer	0.00192	0.00243	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SDHD—adrenal gland cancer	0.00192	0.00243	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00163	0.00207	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MED12—adrenal gland cancer	0.00143	0.00181	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EGFR—adrenal gland cancer	0.0013	0.00164	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TP53—adrenal gland cancer	0.00109	0.00137	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PRKACA—adrenal gland cancer	0.00105	0.00132	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GNAS—adrenal gland cancer	0.000848	0.00107	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCB1—adrenal gland cancer	0.000832	0.00105	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—adrenal gland cancer	0.000571	0.000722	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—adrenal gland cancer	0.000455	0.000576	CbGpPWpGaD
